Lilly Endowment INC
Total reported value
$84.5B
Reporting period: 2026-03-31 · Number of holdings: 1
LILLY ENDOWMENT INC disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $84.5B and a quarterly turnover rate of 15.9%.
Browse other institutions with $10B to $100B AUMBrowse other institutions starting with "L"
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 15.85
- Momentum/Contrarian
- 50
- Sector conviction
- 100
- Diversification
- 2
- Sizing Uniformity
- —
Recent moves
Unchanged LLY
-0.3% -$14.6B
Holdings Map
Institutional Game-State Analysis
LILLY ENDOWMENT INC trimmed its sole holding LLY while keeping portfolio weight pinned at 100% — this is profit-taking within a singular conviction, not a reduction of the thesis. The endowment is reducing absolute exposure to lock in gains on an overweight winner, yet refuses to dilute the concentrated bet that generated the returns.
The portfolio's exclusive Health Care stance is a bet on the GLP-1 obesity drug cycle and the pricing power of branded pharma. The trim signals the institution is pricing in peak multiples or near-term revenue deceleration, anticipating a regime shift from rapid expansion to maturation. The opposing thesis: regulatory risk on drug pricing or a competitor pipeline breakthrough that erodes LLY's market share.
The single-stock structure creates pure idiosyncratic asymmetry — any clinical trial miss or regulatory setback for LLY's key assets (tirzepatide) forces a portfolio liquidation event. The trim reduces absolute exposure but does nothing to hedge the binary outcome. Moreover, as LLY has been a crowded hedge fund long, a coordinated unwind could accelerate losses well beyond any fundamental trigger.
The above is AI-generated from public regulatory filings and summarizes historical data only. It is not investment advice.
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | Stock-Healthcare | 100.00% | — | -0.32% |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | $84.5B | 16 | |
| 2025-12-31 | 1 | $99.1B | 30 | |
| 2025-09-30 | 1 | $72.9B | 9 | |
| 2025-06-30 | 1 | $74.8B | 0 | |
| 2025-03-31 | 1 | $79.3B | 100 | |
| 2024-12-31 | 1 | $74.8B | 0 | |
| 2024-09-30 | 1 | $85.8B | 0 | |
| 2024-06-30 | 1 | $88.2B | 0 | |
| 2024-03-31 | 1 | $76.9B | 0 | |
| 2023-12-31 | 1 | $58.2B | 0 | |
| 2023-09-30 | 1 | $53.7B | 0 | |
| 2023-06-30 | 1 | $47.4B | 0 | |
| 2023-03-31 | 1 | $35.2B | 0 | |
| 2022-12-31 | 1 | $37.7B | 0 | |
| 2022-09-30 | 1 | $33.6B | 0 | |
| 2022-06-30 | 1 | $33.8B | 0 | |
| 2022-03-31 | 1 | $30.4B | 0 | |
| 2021-12-31 | 1 | $29.7B | 0 | |
| 2021-09-30 | 1 | $25.0B | 0 | |
| 2021-06-30 | 1 | $25.1B | 90 | |
| 2021-03-31 | 1 | $20.6B | 9 | |
| 2020-12-31 | 1 | $18.8B | 13 | |
| 2020-09-30 | 1 | $16.4B | 11 | |
| 2020-06-30 | 1 | $18.3B | 15 | |
| 2020-03-31 | 1 | $15.7B | 4 | |
| 2019-12-31 | 1 | $15.1B | 14 | |
| 2019-09-30 | 1 | $13.0B | 1 | |
| 2019-06-30 | 1 | $12.9B | 16 | |
| 2019-03-31 | 1 | $15.2B | 10 | |
| 2018-12-31 | 1 | $13.7B | 6 | |
| 2018-09-30 | 1 | $12.8B | 21 | |
| 2018-06-30 | 1 | $10.4B | 9 | |
| 2018-03-31 | 1 | $9.5B | 9 | |
| 2017-12-31 | 1 | $10.4B | 2 | |
| 2017-09-30 | 1 | $10.6B | 3 | |
| 2017-06-30 | 1 | $10.2B | 3 | |
| 2017-03-31 | 1 | $10.5B | 13 | |
| 2016-12-31 | 1 | $9.2B | 9 | |
| 2016-09-30 | 1 | $10.1B | 1 | |
| 2016-06-30 | 1 | $10.0B | 8 | |
| 2016-03-31 | 1 | $9.2B | 16 | |
| 2015-12-31 | 1 | $10.8B | 1 | |
| 2015-09-30 | 1 | $10.8B | 0 | |
| 2015-06-30 | 1 | $10.8B | 13 | |
| 2015-03-31 | 1 | $9.5B | 5 | |
| 2014-12-31 | 1 | $9.1B | 5 | |
| 2014-09-30 | 1 | $8.6B | 3 | |
| 2014-06-30 | 1 | $8.3B | 4 | |
| 2014-03-31 | 1 | $8.0B | 14 | |
| 2013-12-31 | 1 | $6.9B | 1 | |
| 2013-09-30 | 1 | $6.8B | 2 | |
| 2013-06-30 | 1 | $6.7B | 0 |
Holding changes this quarter
Lilly Endowment INC's most significant position changes for 2026-03-31: Trim: Eli Lilly & Co (LLY) — shares -0.32%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | — | -0.32% | Trim |
FAQ
What is Lilly Endowment INC and what type of investor is it?
What are Lilly Endowment INC's largest equity positions?
What changes did Lilly Endowment INC make in its most recent portfolio filing?
What sectors does Lilly Endowment INC focus on?
Peer Institutions
Institutions with a similar AUM
Belvedere Trading LLC
Total reported value
$84.4B
731 stks
2026-03-31
AUM within 0.1% of this institution
Pictet Asset Management SA
Total reported value
$84.3B
1,970 stks
2023-06-30
AUM within 0.2% of this institution
Sanders Capital, LLC
Total reported value
$83.9B
44 stks
2026-03-31
AUM within 0.7% of this institution
Similar Holdings Style
Institutions with overlapping top holdings
Fifth Third Bancorp
Total reported value
$54.7B
4,303 stks
2026-03-31
1 of the top 5 holdings overlap, including Eli Lilly & Co
State Farm Mutual Automobile Insurance Co
Total reported value
$126.9B
197 stks
2026-03-31
1 of the top 5 holdings overlap, including Eli Lilly & Co
Old National Bancorp /in/
Total reported value
$5.0B
990 stks
2026-06-30
1 of the top 5 holdings overlap, including Eli Lilly & Co